UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...
An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed ...
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
Post-acute neuropsychiatric symptoms triggered by COVID-19 could raise the long-term use of multiple psychoactive drugs in LTC residents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results